Literature DB >> 25056245

Combined oral contraceptives: health benefits beyond contraception.

D Caserta1, E Ralli, E Matteucci, G Bordi, M Mallozzi, M Moscarini.   

Abstract

It has been recognized for over 50 years that combined oral contraceptives (COCs) are also capable of offering health benefits beyond contraception through the treatment and prevention of several gynaecological and medical disorders. During the last years a constant attention was given to the adverse effects of COCs, whereas their non-contraceptive benefits were underestimated. To date, most women are still unaware of the therapeutic uses of hormonal contraceptives, while on the contrary there is an extensive and constantly increasing of these non-contraceptive health benefits. This review summarizes the conditions of special interest for physicians, including dysmenorrhoea, menorrhagia, hyperandrogenism (acne, hirsutism, polycystic ovary syndrome), functional ovarian cysts, endometriosis, premenstrual syndrome, myomas, pelvic inflammatory disease, bone mineral density, benign breast disease and endometrial/ovarian and colorectal cancer. The benefits of COCs in rheumatoid arthritis, multiple sclerosis, menstrual migraine and in perimenopause have also been treated for more comprehensive information. Using COCs specifically for non-contraceptive indications is still outside the product licence in the majority of cases. We strongly believe that these aspects are not of minor relevance and they deserve a special consideration by health providers and by the mass media, which have the main responsibility in the diffusion of scientific information. Thus, counseling and education are necessary to help women make well-informed health-care decisions and it is also crucial to increase awareness among general practitioners and gynaecologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056245

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  6 in total

1.  Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.

Authors:  S Dombrowski; L Jacob; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

2.  Impact of Combined Hormonal Contraceptive Use on Weight Loss: A Secondary Analysis of a Behavioral Weight-Loss Trial.

Authors:  Ann E Caldwell; Adnin Zaman; Danielle M Ostendorf; Zhaoxing Pan; Bryan B Swanson; Suzanne Phelan; Holly R Wyatt; Daniel H Bessesen; Edward L Melanson; Victoria A Catenacci
Journal:  Obesity (Silver Spring)       Date:  2020-06       Impact factor: 5.002

3.  Hormonal Contraceptives Improve Women's Health and Should Continue to Be Covered by Health Insurance Plans.

Authors:  Carol J Hogue; Kelli Stidham Hall; Melissa Kottke
Journal:  Ann Intern Med       Date:  2017-10-03       Impact factor: 25.391

4.  Efficacy of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst) in Polycystic Ovary Syndrome (PCOS).

Authors:  Anand Swaroop; Amrita Sarkari Jaipuriar; Sushil Kumar Gupta; Manashi Bagchi; Pawan Kumar; Harry G Preuss; Debasis Bagchi
Journal:  Int J Med Sci       Date:  2015-10-03       Impact factor: 3.738

5.  How prevalent are symptoms and risk factors of pelvic inflammatory disease in a sexually conservative population.

Authors:  Oqba Al-Kuran; Lama Al-Mehaisen; Hamza Alduraidi; Naser Al-Husban; Balqees Attarakih; Anas Sultan; Zeina Othman; Sanal AlShárat; Shoug AlHilali; Nadia Alkouz; Noura Alibrahim; Wafaa AlMusallam
Journal:  Reprod Health       Date:  2021-05-28       Impact factor: 3.223

6.  Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.

Authors:  Sebastian Simu; Iasmina Marcovici; Amadeus Dobrescu; Daniel Malita; Cristina Adriana Dehelean; Dorina Coricovac; Flavius Olaru; George Andrei Draghici; Dan Navolan
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.